Location: Home
  • search
  • go
  • Relate News
  • 11/21/2023Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
  • 11/21/2023Bimeda Opens £22M China Plant
  • 11/20/2023Roche to Further Explore China's Personalized Healthcare Market Poten...
  • 11/20/2023Aurobindo Pharma's China Plant Gets EU's GMP Approval
  • 11/20/2023Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
  • 11/17/2023China Begins Formal Access Negotiation for the 2023 NRDL
  • 11/17/2023JPO Announces the Final 9th VBP Tender Outcome
  • 11/17/2023Recent Official and Executive Moves
  • 11/16/2023Daewoong Inks MOU with Meheco International to Boost Drug Export to Ch...
  • 11/16/2023PharmCube: Review of Chinese Hospital Drug Market MAT Q2/2023 (2)
  • 11/14/2023CDE Solicits Comments on the Draft Guidelines for Management and Revi...
  • 11/13/2023Nona Announces Strategic Collaboration with GeneQuantum for Early Disc...
  • 11/13/2023Boehringer Ingelheim and ChromX Health Join Hands to Research Lung Dis...
  • 11/13/2023MSD Takes Over AstraZeneca as the Top MNC in China Q3/2023
  • 11/10/2023China's Strength Is Innovation on Innovation, Western Partners Are Lin...
  • 11/9/2023PIC/S Confirms Full Membership Application by NMPA
  • 11/9/2023China Builds Platform to Facilitate Inter-hospital Access to Patient H...
  • 11/9/2023BeiGene and Zymeworks Terminate Partnership on Bi-specific ADC Drug ZW...
  • 11/9/2023AstraZeneca Reports Q3/2023 Performance with Dwindling China Revenue G...
  • 11/9/2023Recent Executive Moves
  • 11/8/2023Menarini Group Out-Licenses Orserdu to SciClone in China
  • 11/8/2023Chinese and Foreign Pharma, MedTech Firms Discuss Cooperation at CIIE
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/7/2023WuXi XDC Eyes Up to $471M in Hong Kong IPO
  • 11/7/2023Bayer Join Hands with Shanghai Pharma for Its Co.Lab Incubator Network...
  • 11/7/2023Moderna Begins Construction of First China Plant during CEO's Visit fo...
  • 11/6/2023BioLineRx, GloriaBio Reach Licensing Deal for Development of Motixafor...
  • 11/6/2023486 A-Listed MedPharma Cos Report Performance in First Three Quarters ...
  • 11/6/2023JPO Publicizes 9th VBP Tender Outcome, Which Cuts Average Price by 58%
  • 11/6/2023Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
  • Page:49/367 Total number of articles:10998: [First][<<] [47] [48] [49] [50] [51] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group